• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during breastfeeding and pregnancy is challenging for women with the condition. There are few data on how does medication for adhd work long-term exposure may affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological developmental conditions like impaired vision or hearing, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality studies are required.

Risk/Benefit Analysis

Pregnant women who use ADHD medications need to balance the benefits of taking them against the potential risks to the foetus. Physicians do not have the information needed to provide clear recommendations but they can provide information about benefits and risks that can assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications during early pregnancy did not have a significantly increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a large population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants in early pregnancy, and those who did not. Clinical geneticists and pediatric cardiologists looked over the cases to ensure an accurate classification of the cases and to reduce the chance of bias.

However, the study was not without its flaws. Most important, they were unable to distinguish the effects of the medication from the disorder that is underlying. This limitation makes it difficult for researchers to determine whether the few associations observed between the groups that were exposed to the use of medication or caused by the presence of comorbidities. In addition, the researchers did not study the long-term outcomes of offspring.

The study did show that infants whose mothers took ADHD medications during pregnancy were at slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or cut back on their medications prior to or during pregnancy. This increase was due to central nervous system-related disorders and the increased risk of admission did not appear to be affected by the type of stimulant medications were taken during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases did appear to be unrelated to the type of medication taken during pregnancy.

The research suggests that the low risk associated with the use of ADHD medications during early pregnancy may be offset by the higher benefit to both the mother and child of continued treatment for the woman's disorder. Physicians should talk to their patients about this and as much as possible, assist them develop coping strategies that may reduce the effects of her disorder on her daily life and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to maintain treatment or stop it during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are made without any evidence that is clear and definitive either way, so physicians must weigh what they know from their own experiences, those of other doctors, and what the research suggests on the subject, along with their own judgments for each individual patient.

Particularly, the subject of potential risks for the baby can be a challenge. The research on this subject is based on observation instead of controlled studies and many of the findings are contradictory. Additionally, the majority of studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study that is discussed in the journal club addresses these limitations by analyzing data on live and deceased births.

The conclusion: While some studies have found a positive association between ADHD medications and the possibility of certain birth defects, others have not found any evidence of a link, and most studies demonstrate a neutral or slightly negative effect. In every case it is imperative to conduct a thorough study of the risks and benefits is required.

It isn't easy, but not impossible for women suffering from ADHD to stop taking their medication. In a recent article in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of loneliness. A loss of medication may affect the ability to safely drive and complete work-related tasks, which are essential aspects of normal life for those with ADHD.

She recommends women who are unsure about whether or not to stop taking medication because of their pregnancy consider educating family members, friends and colleagues on the condition, its impact on daily functioning, and the advantages of continuing the current treatment regimen. Educating them can also make the woman feel more comfortable as she struggles with her decision. Some medications can pass through the placenta. If a woman decides to not take her adhd medication for adults uk medication while pregnant and breastfeeding, it is important to be aware that the drug may be transferred to her infant.

Birth Defects and Risk of

As the use and misuse of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) is increasing as does the concern about the potential adverse effects of the drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Utilizing two huge data sets, researchers were able to analyze more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that although the overall risk is low, first-trimester adhd inattentive type medication (https://fifthcrab35.bravejournal.net/) medication use was associated with slightly higher rates of specific heart defects such as ventriculoseptal defect.

The authors of the study found no association between early medication use and other congenital anomalies, such as facial clefting or club foot. The results are consistent with previous studies revealing the presence of a small, but significant increase in the risk of developing cardiac malformations in women who started taking ADHD medications prior to the birth of their child. The risk increased in the latter part of pregnancy, when a lot of women began to stop taking their medication.

Women who used ADHD medication in the first trimester of their pregnancy were also more likely to have caesarean sections, a low Apgar score following delivery, and a baby who required breathing assistance during birth. However the researchers of the study were not able to eliminate selection bias by restricting the study to women who didn't have any other medical issues that could have contributed to the findings.

Researchers hope their research will provide doctors with information when they meet pregnant women. They suggest that although a discussion of the risks and benefits is crucial however, the decision to stop or keep treatment should be based on each woman's needs and the severity of her ADHD symptoms.

The authors warn that, even though stopping the medication is a possibility to look into, it is not recommended because of the high incidence of depression and other mental problems among women who are pregnant or have recently given birth. Research has also shown that women who stop taking their medication will have a tough time adjusting to a life without them after the baby is born.

Nursing

It can be a stressful experience to become a mother. Women with ADHD who have to deal with their symptoms while attending doctor appointments, making preparations for the arrival of a baby and adapting to new routines in the home may face a lot of challenges. Therefore, many women decide to continue taking their ADHD medications throughout the course of pregnancy.

The risk to a nursing infant is low because the majority of stimulant medication is absorbed through breast milk in low amounts. However, the rate of exposure to medication by the infant can differ based on dosage, frequency it is administered and the time of the day the medication is administered. In addition, various medications enter the baby’s system via the gastrointestinal tract, or through breast milk. The impact of these medications on the health of a newborn isn't fully understood.

Some physicians may discontinue stimulant medication during a woman's pregnancy due to the absence of research. This is a difficult decision for the mother, who must weigh the benefits of her medication against the risks to the fetus. As long as more information is available, doctors can inquire about pregnant patients if they have any history of ADHD or if they are planning to take medication in the perinatal phase.

A growing number of studies have revealed that women can continue to take their adhd medication making it worse medication during pregnancy and while breastfeeding. This has led to an increasing number of patients choose to do so and in consultation with their doctor they have found that the benefits of continuing their current medication far outweigh any potential risks.

Women with ADHD who plan to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss the medication they are taking with their physician and discuss the pros and cons for continuing treatment. This includes non amphetamine adhd medication-pharmacological methods. Psychoeducation is also required to help pregnant women with ADHD recognize the signs and underlying disorder. They should also be informed about treatment options and strengthen the coping mechanisms. This should include a multidisciplinary approach, which includes the GP, obstetricians and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother and child, monitoring of signs of deterioration, and, if necessary adjustments to the medication regimen.